Skip to main content

11-06-2021 | ASCO 2021 | Conference coverage | Video

Key considerations for the VISION trial of LuPSMA in mCRPC

Mary-Ellen Taplin provides an independent perspective on the efficacy and safety results of the VISION trial and outlines the key unanswered research questions (5:29).

Read transcript

Related content

31-05-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: The TheraP trial

Image Credits